A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

United States, Maryland National Institutes of Health **RECRUITING NOW** Bethesda, Maryland, United States, 20892 Contact: Erica Redmond    240-858-3783       Principal Investigator: James Gulley, MD, PhD          United States, Massachusetts Massachusetts General Hospital Cancer Center **RECRUITING NOW** Boston, Massachusetts, United States, 02114 Contact: Ryan Sullivan, MD    617-643-3614       Principal Investigator: Ryan Sullivan, MD          United States, New York Memorial Sloan-Kettering Cancer Center **RECRUITING NOW** New York, New York, United States, 10065 Contact: Claire Friedman, MD    646-888-4247       Principal Investigator: Claire Friedman, MD          Canada, Ontario Princess Margaret Cancer Centre **RECRUITING NOW** Toronto, Ontario, Canada, M5G 2C4 Contact: Lillian Siu, MD    416-946-2911       Principal Investigator: Lillian Siu, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.